Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.04 USD | -1.82% | -4.04% | +44.82% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 49
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
Sandeep Laumas
DFI | Director of Finance/CFO | 56 | 20-05-31 |
Mark Dudley
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Robert Hawkins
CTO | Chief Tech/Sci/R&D Officer | 69 | 22-11-10 |
John Moore
PRN | Corporate Officer/Principal | 59 | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Gibson
BRD | Director/Board Member | 67 | 20-05-31 |
Richard McGaughy
BRD | Director/Board Member | 52 | 20-05-31 |
Director/Board Member | 49 | 20-06-30 | |
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
George Matcham
BRD | Director/Board Member | 72 | 18-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,503,913 | 6,058,922 ( 93.16 %) | 0 | 93.16 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.82% | 71.77M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- TIL Stock
- Company Instil Bio, Inc.